Literature DB >> 8387135

Inverse regulation of alpha- and beta-adrenoceptors during trinitrobenzenesulfonic acid (TNB)-induced inflammation in guinea-pig small intestine.

J P Martinolle1, J Moré, N Dubech, R Garcia-Villar.   

Abstract

The hypothesis has been raised that intestinal motor disturbances induced by inflammation of the digestive tract may reflect alterations in intestinal cell-membrane receptors. This question has been addressed herein for adrenoceptors by performing [3H]prazosin, [3H]rauwolscine and [3H]DHA binding studies on guinea-pig jejunal smooth-muscle membrane preparations from both healthy controls and 3, 6, and 10 days after TNB-induced intestinal inflammation. Each of the adrenoceptor subtype-selective radioligands used bound selectively to a single saturable class of sites, with no significant (p < 0.05) variation of dissociation constant (KD) values along the inflammatory process. In contrast maximal binding capacities (Bmax) for the different radioligands varied moderately but significantly (p < 0.05 and p < 0.01) according to the time after TNB injection. The alpha-adrenoceptors were significantly upregulated, respectively from (mean +/- SE in fmoles/mg of proteins) 27 +/- 3.8 (controls) to 91 +/- 3.1 (day 10) for the alpha 1-subtype, and from 26 +/- 2.7 (controls) to 102 +/- 5.9 (day 10) for the alpha 2-subtype. In contrast beta-adrenoceptors were down-regulated from 384 +/- 34.6 (controls) to 158 +/- 17.2 (day 10). These findings highlighted an apparently inverse pathological regulation of intestinal alpha- and beta- adrenoceptor densities. They suggest that changes in intestinal adrenoceptors, probably resulting from functional denervation of the inflamed bowel tissue, may contribute to the altered intestinal motility observed in inflammatory bowel diseases.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8387135     DOI: 10.1016/0024-3205(93)90112-g

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  8 in total

Review 1.  Ghrelin-mediated sympathoinhibition and suppression of inflammation in sepsis.

Authors:  Cletus Cheyuo; Asha Jacob; Ping Wang
Journal:  Am J Physiol Endocrinol Metab       Date:  2011-11-08       Impact factor: 4.310

2.  Correlation of desensitisation of platelet activating factor (PAF) receptors with intensity of inflammation and intestinal PAF content during experimental ileitis in guinea pig.

Authors:  O Jeanneton; M Delvaux; Y Langlois; P Le Bars; J Le Bars; M B Delisle; J Frexinos; L Bueno
Journal:  Gut       Date:  1998-09       Impact factor: 23.059

Review 3.  The role of the sympathetic nervous system in intestinal inflammation.

Authors:  R H Straub; R Wiest; U G Strauch; P Härle; J Schölmerich
Journal:  Gut       Date:  2006-11       Impact factor: 23.059

4.  Morphological and functional alterations of the myenteric plexus in rats with TNBS-induced colitis.

Authors:  E Poli; M Lazzaretti; D Grandi; C Pozzoli; G Coruzzi
Journal:  Neurochem Res       Date:  2001-09       Impact factor: 3.996

Review 5.  Divergent neuroendocrine responses to localized and systemic inflammation.

Authors:  Mark K Lukewich; Richard C Rogers; Alan E Lomax
Journal:  Semin Immunol       Date:  2014-01-31       Impact factor: 11.130

6.  The inhibitory effects of alpha(2)-adrenoceptor agonists on gastrointestinal transit during croton oil-induced intestinal inflammation.

Authors:  O Pol; L Valle; I Ferrer; M M Puig
Journal:  Br J Pharmacol       Date:  1996-12       Impact factor: 8.739

Review 7.  Neuroimmune Interaction: A Widespread Mutual Regulation and the Weapons for Barrier Organs.

Authors:  Yan Zhu; Shixin Duan; Mei Wang; Zhili Deng; Ji Li
Journal:  Front Cell Dev Biol       Date:  2022-05-11

8.  Altered prejunctional modulation of intestinal cholinergic and noradrenergic pathways by alpha2-adrenoceptors in the presence of experimental colitis.

Authors:  Corrado Blandizzi; Matteo Fornai; Rocchina Colucci; Fabio Baschiera; Giovanni Barbara; Roberto De Giorgio; Fabrizio De Ponti; Maria Cristina Breschi; Mario Del Tacca
Journal:  Br J Pharmacol       Date:  2003-05       Impact factor: 8.739

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.